Rhinitis

Related records

Broader conditions (11)

• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Human disease
• Inflammatory disease
• Mucositis
• Nasal cavity disorder
• Nasal disorder
• Otorhinolaryngologic disease
• Respiratory system disorder
• Upper respiratory tract disorder

Narrower conditions (7)

• Allergic rhinitis
• Atrophic rhinitis
• Chronic rhinitis
• Empty nose syndrome
• Perennial allergic rhinitis
• Seasonal allergic rhinitis
• Vasomotor rhinitis

Trials (701)

• 4"S" - Seasonal Symptoms Suppression Study
• 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis
• 723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover
• A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis
• A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
• A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)
• A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
• A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients
• A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
• A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
• A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis
• A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis
• A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.
• A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)
• A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
• A Comparison Between Co-phenylcaine Nasal Spray and Nasal Nebulization Prior to Rigid Nasoendoscopic Examination
• A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers
• A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures
• A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
• A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy

Approved drugs (2)

• Flunisolide
• Omalizumab

Drugs in development (19)

• Andolast Phase 3
• AWD-12-281 Phase 2
• Cetirizine Phase 2
• Diphenhydramine Phase 3
• Dropropizine Phase 3
• Efletirizine Phase 2
• Etiprednol dicloacetate Phase 2
• Fluticasone furoate Phase 3
• Fluticasone propionate Phase 2
• Levocetirizine Phase 3
• Levocetirizine dihydrochloride Phase 3
• Linetastine Phase 2
• Montelukast sodium Phase 1
• Onabotulinumtoxina Phase 2
• Phenylephrine hydrochloride Phase 1
• Pseudoephedrine Phase 3
• SB-705498 Phase 2
• Sodium chloride Phase 3
• Triamcinolone acetonide Phase 3

Other linked drugs (5)

• Cyproheptadine
• Desloratadine
• Dexchlorpheniramine maleate
• Fluticasone
• Vitamin E